ECI

Pharmaceuticals

Established in 2010, ECI is a pharmaceutical company that focuses on developing and marketing products that are manufactured at its cGMP facility located in Fort Lauderdale, Florida.   Over the years, ECI has been a trusted name in pharmaceutical manufacturing providing affordable generic medication to consumers through its vast distribution channels.  Our customer base includes all major Wholesalers, Retailers,  Group Purchasing Organizations, Long Term Care, and Hospitals.

Pharmaceutical Manufacturer

LEARN MORE

We bring years of experience that emphasizes quality, speed and flexibility, with a full range of efficient and cost effective manufacturing solutions.

Contact Us Today (954) 486-8181

LEARN MORE

To learn more about ECI Pharmaceuticals, our products and manufacturing facility, please contact us. We look forward to hearing from you.

Since 2010, ECI has been a pharmaceutical company focused on developing and marketing products that are manufactured at its cGMP facility located in Fort Lauderdale, Florida. Over the years, ECI has been a trusted name in pharmaceutical manufacturing providing affordable medicine to consumers through its vast distribution channels. Our customer base includes all major Wholesalers, Retailers, and Group Purchasing Organizations.

Pharmaceutical Manufacturer

We bring years of experience that emphasizes quality, speed and flexibility, with a full range of efficient and cost effective manufacturing solutions.

Contact Us Today — (954) 486-8181

To learn more about ECI Pharmaceuticals, our products and manufacturing facility, please contact us. We look forward to hearing from you.

MISSION

Quality Statement

ECI Pharmaceuticals is committed to delivering the highest quality products to satisfy consumer expectations while meeting all regulatory requirements.

PROVEN

Results

ECI seeks out opportunities where there may be shortages or where improvements can be made on existing products. We are currently filing several NDAs and ANDAs with the Food and Drug Administration utilizing the 505(b)(2) pathway.